VIVUS (VVUS) Peers Pressured as Analyst Takes Cautious Stance on Obesity Drug (ARNA) (OREX)
Tweet Send to a Friend
Amid Jefferies downgrading VIVUS (Nasdaq: VVUS) earlier on risk of generic prescriptions, peers are feeling the pressure Friday ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
